Welcome To www.LupusMCTD.com

Other Medical Information Photobucket => PhotobucketFibromyalgia => Topic started by: Adminஐﻬ on August 17, 2008, 07:29:19 pm

Post by: Adminஐﻬ on August 17, 2008, 07:29:19 pm
New thread for those with Fibro to talk to each other

Title: Lilly sponsors chronic pain website
Post by: Adminஐﻬ on September 17, 2009, 12:27:31 pm
Lilly sponsors chronic pain website
September 16, 2009

Lilly is sponsoring a new website looking at the problems of the widespread chronic pain condition fibromyalgia.

KnowFibro.com has been produced in collaboration with the National Fibromyalgia Association, and has been launched to coincide with September's National Pain Awareness Month in the US.

Lilly's Cymbalta (duloxetine) received FDA approval to treat fibromyalgia in June 2008, bringing it into competition with Pfizer's Lyrica (pregabalin), which in 2007 become the first treatment to be given the green light in the US.

The Know Fibro campaign is primarily about raising awareness of fibromyalgia, and the website carries information resources, tips and a suggested self-management programme.

KnowFibro.com also features an online video diary detailing the experiences of fibromyalgia sufferer Martha Beck, who has had the condition for 30 years.

She says it represents "an honest look into how the disorder has impacted every aspect of my life".

But Beck adds that she has also got her fibromyalgia under control with a comprehensive care plan.

The disorder is characterised by the presence of chronic widespread pain and tenderness for at least three months.

Often misunderstood, fibromyalgia is frequently accompanied by fatigue, emotional changes and sleep problems.

Lilly says a combination of medication, education and lifestyle change is seen as the best way of mitigating the effects of the condition.

Lilly's Cymbalta was originally launched in 2004 for the treatment of neuropathic pain and the control of epileptic seizures, but the drug has not fared so well with regulators since then.

In June this year the company had to resubmit its supplemental New Drug Application (sNDA), along with new studies, for Cymbalta in the management of chronic pain to the US regulator.

Lilly originally submitted the sNDA early last year but withdrew it in November and the company said its subsequent discussions with the FDA were "primarily about statistical methodology and study design".

Meanwhile in Europe, where Lilly co-markets Cymbalta with Boehringer Ingelheim, a key regulatory advisory committee rejected the depression treatment's use to alleviate fibromyalgia.

The decision means that there is still no treatment approved in Europe for fibromyalgia, which in the US affects an estimated five million people.

Page Contents, Layout, Graphics and Design All Copyrighted by Credited Artists and are Not Public Domain.

LupusMCTD Founder & Patient
Former Domestic Violence SURVIVOR
Kathy A. Patterson

Author of the Upcoming Memoir Book:
"Fighting From The Inside Out"..
A lupus patient fights the beast within her immune system and the beast at home....

e-Booklet filled with photos and videos of what abuse was, signs to look for,
where to turn to for help, and much more to help others like me...

For more information
Call the National Domestic Violence Hotline at 1−800−799−SAFE(7233)

"The Meaning of the Words in the Second Amendment .... "That the people have a right to freedom of speech, and of writing, and publishing their sentiments;"

PRIVACY NOTICE: Warning--any person and/or institution and/or Agent and/or Agency of any governmental structure including but not limited to the United States Federal Government also using or monitoring/using this website or any of its associated websites, you do NOT have my permission to utilize any of my profile information nor any of the content contained herein including, but not limited to my photos, and/ or the comments made about my photo's or any other "picture" art posted on my profile. You are hereby notified that you are strictly prohibited from disclosing, copying, distributing, disseminating, or taking any other action against me with regard to this profile and the contents herein. The foregoing prohibitions also apply to your employee(s), agent(s), student(s) or any personnel under your direction or control. The contents of this profile are private and legally privileged and confidential information, and the violation of my personal privacy is punishable by law
2008 LupusMCTD Foundation of America - All Rights Reserved
Est.November 11, 2005
"We Understand What You Are Going Through"